<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01054807</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0915</org_study_id>
    <secondary_id>CTN# 155/2009</secondary_id>
    <nct_id>NCT01054807</nct_id>
  </id_info>
  <brief_title>Non-Dispensing Evaluation of an Investigational Galyfilcon A Soft Contact Lens</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coles-Brennan Pty Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this investigation is to compare the fit characteristics and vision attributes
      of an investigational Galyfilcon A contact lens and an approved Galyfilcon A contact lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2009</start_date>
  <completion_date type="Actual">March 1, 2010</completion_date>
  <primary_completion_date type="Actual">March 1, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Lens Fit Characteristics</measure>
    <time_frame>Approximately 40 minutes of wear time</time_frame>
    <description>At the screening visit, the following baseline measurements will be taken of the subject's habitual contact lenses (Control):
Visual Acuity (logMar)
Over-refraction with Visual Acuity
Fit acceptability (acceptable/non-acceptable)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of Inter-Changeability</measure>
    <time_frame>Approximately 40 minutes of wear time</time_frame>
    <description>In a bilateral fashion, the subject will wear Test/Control lens according to a pre-designed randomization schedule. Immediately upon insertion, the following variables will be assessed:
Ease of handling of the lenses- by Investigator
Comfort on insertion
After 30-40 minutes of settling time the following variables will be collected:
Subjective comfort after settling
Visual Acuity (logMar)
Corneal coverage (Y/N)
Post-blink movement (mm)
Version Lag (mm)
Tightness on push-up (0-100 scale)
Overall fit acceptance (0-5 scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determination of fit or Vision Differences</measure>
    <time_frame>Approximately 40 minutes of wear time</time_frame>
    <description>In a bilateral fashion, the subject will wear Test/Control lens according to a pre-designed randomization schedule. Immediately upon insertion, the following variables will be assessed:
Ease of handling of the lenses- by Investigator
Comfort on insertion
After 30-40 minutes of settling time the following variables will be collected:
Subjective comfort after settling
Visual Acuity (logMar)
Corneal coverage (Y/N)
Post-blink movement (mm)
Version Lag (mm)
Tightness on push-up (0-100 scale)
Overall fit acceptance (0-5 scale)</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>GalyfilconHL/Galyfilcon8.7/Galyfilcon8.3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Galyfilcon A Habitual Lens (Active Comparator)/Galyfilcon A 8.7 BC (Experimental)/Galyfilcon A 8.3 BC (Experimental)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Galyfilcon8.7/Galyfilcon8.3/GalyfilconHL</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Galyfilcon A 8.7 BC (Experimental)/Galyfilcon A 8.3 BC (Experimental)/Galyfilcon A Habitual Lens (Active Comparator)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GalyfilconHL/Galyfilcon8.3/Galyfilcon8.7</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Galyfilcon A Habitual Lens (Active Comparator)/Galyfilcon A 8.3 BC (Experimental)/Galyfilcon A 8.7 BC (Experimental)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Galyfilcon 8.7/Galyfilcon HL/Galyfilcon 8.3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Galyfilcon A 8.7 BC (Experimental)/Galyfilcon A Habitual Lens (Active Comparator) /Galyfilcon A 8.3 BC (Experimental)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Galyfilcon8.3/GalyfilconHL/Galyfilcon8.7</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Galyfilcon A 8.3 BC (Experimental)/Galyfilcon A Habitual Lens (Active Comparator)/Galyfilcon A 8.7 BC (Experimental)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Galyfilcon8.3/Galyfilcon8.7/GalyfilconHL</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Galyfilcon A 8.3 BC (Experimental)/Galyfilcon A 8.7 BC (Experimental)/Galyfilcon A Habitual Lens (Active Comparator)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Galyfilcon A Habitual Lens</intervention_name>
    <description>Comparison of three soft contact lens designs.</description>
    <arm_group_label>GalyfilconHL/Galyfilcon8.7/Galyfilcon8.3</arm_group_label>
    <arm_group_label>Galyfilcon8.7/Galyfilcon8.3/GalyfilconHL</arm_group_label>
    <arm_group_label>GalyfilconHL/Galyfilcon8.3/Galyfilcon8.7</arm_group_label>
    <arm_group_label>Galyfilcon 8.7/Galyfilcon HL/Galyfilcon 8.3</arm_group_label>
    <arm_group_label>Galyfilcon8.3/GalyfilconHL/Galyfilcon8.7</arm_group_label>
    <arm_group_label>Galyfilcon8.3/Galyfilcon8.7/GalyfilconHL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Galyfilcon A 8.7 BC (Investigational)</intervention_name>
    <description>Comparison of three soft contact lens designs.</description>
    <arm_group_label>GalyfilconHL/Galyfilcon8.7/Galyfilcon8.3</arm_group_label>
    <arm_group_label>Galyfilcon8.7/Galyfilcon8.3/GalyfilconHL</arm_group_label>
    <arm_group_label>GalyfilconHL/Galyfilcon8.3/Galyfilcon8.7</arm_group_label>
    <arm_group_label>Galyfilcon 8.7/Galyfilcon HL/Galyfilcon 8.3</arm_group_label>
    <arm_group_label>Galyfilcon8.3/GalyfilconHL/Galyfilcon8.7</arm_group_label>
    <arm_group_label>Galyfilcon8.3/Galyfilcon8.7/GalyfilconHL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Galyfilcon A 8.3 BC (Investigational)</intervention_name>
    <description>Comparison of three soft contact lens designs</description>
    <arm_group_label>GalyfilconHL/Galyfilcon8.7/Galyfilcon8.3</arm_group_label>
    <arm_group_label>Galyfilcon8.7/Galyfilcon8.3/GalyfilconHL</arm_group_label>
    <arm_group_label>GalyfilconHL/Galyfilcon8.3/Galyfilcon8.7</arm_group_label>
    <arm_group_label>Galyfilcon 8.7/Galyfilcon HL/Galyfilcon 8.3</arm_group_label>
    <arm_group_label>Galyfilcon8.3/GalyfilconHL/Galyfilcon8.7</arm_group_label>
    <arm_group_label>Galyfilcon8.3/Galyfilcon8.7/GalyfilconHL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be of legal age (i.e., at least 18 years old)

          -  Sign a written informed consent

          -  Have contact lens distance sphere requirement in the range -1.00D to -6.00D

          -  Have spectacle astigmatism &lt;1.25D in each eye

          -  Currently wear ACUVUE® ADVANCE™ (for at least 6 months) with documentation of current
             prescription.

          -  Have normal eyes with no evidence of abnormality or disease.

        Exclusion Criteria:

          -  Required concurrent ocular medication

          -  Any systemic illness which would contra-indicate lens wear or the medical treatment of
             which would affect vision or successful lens wear.

          -  Eye injury or surgery within eight weeks immediately prior to enrollment for this
             study.

          -  Abnormal lacrimal secretions

          -  Pre-existing ocular irritation that would preclude contact lens fitting.

          -  Keratoconus or other corneal irregularity.

          -  Pregnancy, lactating or planning a pregnancy at the time of enrolment.

          -  Participation in any concurrent clinical trial

          -  Known allergy to silver, silver ions, or silver containing compounds.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noel Brennan, McOptom PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Coles-Brennan Pty Ltd</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coles-Brennan Pty Ltd</name>
      <address>
        <city>Hawthorn</city>
        <state>Victoria</state>
        <zip>3122</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2010</study_first_submitted>
  <study_first_submitted_qc>January 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2010</study_first_posted>
  <disposition_first_submitted>June 16, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>June 16, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">June 20, 2017</disposition_first_posted>
  <last_update_submitted>June 16, 2017</last_update_submitted>
  <last_update_submitted_qc>June 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

